Premium Content Editorial content

Trends in neuroscience dealmaking

Early-stage developments are attracting investment and driving dealmaking within the challenging neuroscience field, particularly for pain and Alzheimer’s disease, as the industry aims to move past the many late-stage clinical failures in recent years.

Go to the profile of BioPharma Dealmakers
Nov 12, 2018

Please sign in or register for FREE

Register to BioPharma Dealmakers

From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.


No comments yet.